Identifying and testing potential new anti-asthma

Author： Fang Cailong Corrigan Chris J Ying Sun

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.10, 2011-10, pp. : 1027-1044

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lung Remodeling in Asthma: A New Target of Anti-Asthma Therapy

Drug Design Reviews - Online, Vol. 2, Iss. 2, 2005-03 ,pp. : 129-136

Bentham Science Publishers

Access to resources Recommend Favorite

New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease

By Belvisi Maria G Hele David J Birrell Mark A

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 4, 2004-08 ,pp. : 265-285

Informa Healthcare

Access to resources Recommend Favorite

Anti-IgE monoclonal antibody, omalizumab: a new treatment for allergic asthma

By Chung K Fan

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 439-446

Informa Healthcare

Access to resources Recommend Favorite

The anti-inflammatory properties of the phosphodiesterase (PDE)-5 inhibitor, sildenafil, make it a potential therapy for asthma and COPD

Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Anti-IgE Therapy with Omalizumab for Severe Asthma: Current Concepts and Potential Developments

Current Drug Targets, Vol. 16, Iss. 2, 2015-02 ,pp. : 171-178

Bentham Science Publishers

Access to resources Recommend Favorite